CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $101,000 | +114.9% | 5,978 | +52.5% | 0.01% | +100.0% |
Q1 2020 | $47,000 | -60.8% | 3,919 | -60.3% | 0.00% | -40.0% |
Q4 2019 | $120,000 | +160.9% | 9,883 | +141.0% | 0.01% | +150.0% |
Q2 2019 | $46,000 | +142.1% | 4,100 | +156.2% | 0.00% | +100.0% |
Q1 2019 | $19,000 | -98.2% | 1,600 | -97.9% | 0.00% | -98.6% |
Q4 2018 | $1,035,000 | +30.0% | 77,506 | +36.5% | 0.07% | +50.0% |
Q3 2018 | $796,000 | -12.3% | 56,769 | -1.7% | 0.05% | -19.3% |
Q2 2018 | $908,000 | -2.8% | 57,769 | +1.8% | 0.06% | -16.2% |
Q1 2018 | $934,000 | -0.2% | 56,769 | +9.6% | 0.07% | -9.3% |
Q4 2017 | $936,000 | +50.0% | 51,801 | +60.1% | 0.08% | +33.9% |
Q3 2017 | $624,000 | +297.5% | 32,349 | +142.7% | 0.06% | +273.3% |
Q2 2017 | $157,000 | -18.2% | 13,329 | -24.0% | 0.02% | -16.7% |
Q1 2017 | $192,000 | -29.4% | 17,529 | -53.2% | 0.02% | -45.5% |
Q4 2016 | $272,000 | +361.0% | 37,429 | +214.5% | 0.03% | +266.7% |
Q4 2015 | $59,000 | +31.1% | 11,900 | 0.0% | 0.01% | +28.6% |
Q3 2015 | $45,000 | – | 11,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |